Société Albireo Pharma, Inc.
Actions
ALBO
US01345P1066
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 130
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Founder | 60 | 08/12/03 | |
President | 57 | 02/03/23 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 13/04/21 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 19/12/22 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/23 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 02/03/23 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 04/11/19 |
Muffy Carter
LAW | General Counsel | 71 | 29/11/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 54 | 02/03/23 | |
Director/Board Member | 61 | 02/03/23 | |
Ronald Cooper
CEO | Chief Executive Officer | 61 | 01/06/15 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 20 709 043 | 18 650 831 ( 90,06 %) | 7 760 ( 0,0375 %) | 90,06 % |
Coordonnées société
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+2,49 % | 96,73 Md | |
-0,17 % | 21,31 Md | |
-16,61 % | 21,21 Md | |
-4,92 % | 18,79 Md | |
-42,14 % | 16,37 Md | |
-27,40 % | 13,68 Md | |
+1,44 % | 13,44 Md | |
+21,29 % | 10,98 Md | |
-21,79 % | 8,56 Md |